304 related articles for article (PubMed ID: 33104171)
1. Adiponectin restrains ILC2 activation by AMPK-mediated feedback inhibition of IL-33 signaling.
Wang L; Luo Y; Luo L; Wu D; Ding X; Zheng H; Wu H; Liu B; Yang X; Silva F; Wang C; Zhang X; Zheng X; Chen J; Brigman J; Mandell M; Zhou Z; Liu F; Yang XO; Liu M
J Exp Med; 2021 Feb; 218(2):. PubMed ID: 33104171
[TBL] [Abstract][Full Text] [Related]
2. Group 2 innate lymphoid cells contribute to IL-33-mediated alleviation of cardiac fibrosis.
Chen WY; Wu YH; Tsai TH; Li RF; Lai AC; Li LC; Yang JL; Chang YJ
Theranostics; 2021; 11(6):2594-2611. PubMed ID: 33456562
[No Abstract] [Full Text] [Related]
3. The NF-κB Transcription Factor c-Rel Modulates Group 2 Innate Lymphoid Cell Effector Functions and Drives Allergic Airway Inflammation.
Mindt BC; Krisna SS; Duerr CU; Mancini M; Richer L; Vidal SM; Gerondakis S; Langlais D; Fritz JH
Front Immunol; 2021; 12():664218. PubMed ID: 34867937
[TBL] [Abstract][Full Text] [Related]
4. Th2 cell-derived IL-4/IL-13 promote ILC2 accumulation in the lung by ILC2-intrinsic STAT6 signaling in mice.
Symowski C; Voehringer D
Eur J Immunol; 2019 Sep; 49(9):1421-1432. PubMed ID: 31144294
[TBL] [Abstract][Full Text] [Related]
5. SLAM-family receptors promote resolution of ILC2-mediated inflammation.
Wang Y; Quan Y; He J; Chen S; Dong Z
Nat Commun; 2024 Jun; 15(1):5056. PubMed ID: 38871792
[TBL] [Abstract][Full Text] [Related]
6. IL-33 causes thermogenic failure in aging by expanding dysfunctional adipose ILC2.
Goldberg EL; Shchukina I; Youm YH; Ryu S; Tsusaka T; Young KC; Camell CD; Dlugos T; Artyomov MN; Dixit VD
Cell Metab; 2021 Nov; 33(11):2277-2287.e5. PubMed ID: 34473956
[TBL] [Abstract][Full Text] [Related]
7. Metabolic regulation by PPARγ is required for IL-33-mediated activation of ILC2s in lung and adipose tissue.
Fali T; Aychek T; Ferhat M; Jouzeau JY; Busslinger M; Moulin D; Eberl G
Mucosal Immunol; 2021 May; 14(3):585-593. PubMed ID: 33106586
[TBL] [Abstract][Full Text] [Related]
8. A Disintegrin and Metalloproteinase 17 is required for ILC2 responses to IL-33.
Lownik JC; Conrad DH; Martin RK
Biochem Biophys Res Commun; 2019 May; 512(4):723-728. PubMed ID: 30926166
[TBL] [Abstract][Full Text] [Related]
9. Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33/ST2 pathway.
Wang D; Bai S; Cui Y; Zhao N; Qi F; Liu J; Zeng S; Xu L; Hu H; Liu B
Immunotherapy; 2018 Sep; 10(12):1065-1076. PubMed ID: 30027786
[TBL] [Abstract][Full Text] [Related]
10. IL-33-driven ILC2/eosinophil axis in fat is induced by sympathetic tone and suppressed by obesity.
Ding X; Luo Y; Zhang X; Zheng H; Yang X; Yang X; Liu M
J Endocrinol; 2016 Oct; 231(1):35-48. PubMed ID: 27562191
[TBL] [Abstract][Full Text] [Related]
11. The Prostaglandin D
Oyesola OO; Duque C; Huang LC; Larson EM; Früh SP; Webb LM; Peng SA; Tait Wojno ED
J Immunol; 2020 Feb; 204(4):1001-1011. PubMed ID: 31900341
[TBL] [Abstract][Full Text] [Related]
12. TLR7 Agonist Suppresses Group 2 Innate Lymphoid Cell-mediated Inflammation via IL-27-Producing Interstitial Macrophages.
Okuzumi S; Miyata J; Kabata H; Mochimaru T; Kagawa S; Masaki K; Irie M; Morita H; Fukunaga K
Am J Respir Cell Mol Biol; 2021 Sep; 65(3):309-318. PubMed ID: 34003734
[TBL] [Abstract][Full Text] [Related]
13. Targeting androgen signaling in ILC2s protects from IL-33-driven lung inflammation, independently of KLRG1.
Blanquart E; Mandonnet A; Mars M; Cenac C; Anesi N; Mercier P; Audouard C; Roga S; Serrano de Almeida G; Bevan CL; Girard JP; Pelletier L; Laffont S; Guéry JC
J Allergy Clin Immunol; 2022 Jan; 149(1):237-251.e12. PubMed ID: 33964300
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E
Zhou Y; Wang W; Zhao C; Wang Y; Wu H; Sun X; Guan Y; Zhang Y
Front Immunol; 2018; 9():501. PubMed ID: 29593738
[TBL] [Abstract][Full Text] [Related]
15. IL-17-producing ST2
Cai T; Qiu J; Ji Y; Li W; Ding Z; Suo C; Chang J; Wang J; He R; Qian Y; Guo X; Zhou L; Sheng H; Shen L; Qiu J
J Allergy Clin Immunol; 2019 Jan; 143(1):229-244.e9. PubMed ID: 29625134
[TBL] [Abstract][Full Text] [Related]
16. c-Rel Is Required for IL-33-Dependent Activation of ILC2s.
Zaini A; Fulford TS; Grumont RJ; Runting J; Rodrigues G; Ng J; Gerondakis S; Zaph C; Scheer S
Front Immunol; 2021; 12():667922. PubMed ID: 34194431
[TBL] [Abstract][Full Text] [Related]
17. Neuropilin-1 mediates lung tissue-specific control of ILC2 function in type 2 immunity.
Zhang J; Qiu J; Zhou W; Cao J; Hu X; Mi W; Su B; He B; Qiu J; Shen L
Nat Immunol; 2022 Feb; 23(2):237-250. PubMed ID: 35075279
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-155 is a critical regulator of type 2 innate lymphoid cells and IL-33 signaling in experimental models of allergic airway inflammation.
Johansson K; Malmhäll C; Ramos-Ramírez P; Rådinger M
J Allergy Clin Immunol; 2017 Mar; 139(3):1007-1016.e9. PubMed ID: 27492144
[TBL] [Abstract][Full Text] [Related]
19. Globular Adiponectin Inhibits Lipopolysaccharide-Primed Inflammasomes Activation in Macrophages via Autophagy Induction: The Critical Role of AMPK Signaling.
Kim MJ; Kim EH; Pun NT; Chang JH; Kim JA; Jeong JH; Choi DY; Kim SH; Park PH
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28617316
[TBL] [Abstract][Full Text] [Related]
20. Adenosine restrains ILC2-driven allergic airway inflammation via A2A receptor.
Xiao Q; Han X; Liu G; Zhou D; Zhang L; He J; Xu H; Zhou P; Yang Q; Chen J; Zhou J; Jiang G; Yao Z
Mucosal Immunol; 2022 Feb; 15(2):338-350. PubMed ID: 34921233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]